Quarterly Transactions Made in Sigilon Therapeutics, Inc. (SGTX)
This table provides information about the institutional ownership of Sigilon Therapeutics, Inc. (SGTX). The information is specifically focused on institutions that hold shares of Sigilon Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q4 2020 | 0 | 17,348,111 | 17,348,111 | — | 17,348,111 | |||
| Q1 2021 | 482,637 | 294,864 | 777,501 | 326,436 | 911,302 | 1,237,738 | -460,237 | |
| Q2 2021 | 474,993 | 3,113,004 | 3,587,997 | 645,801 | 1,037,421 | 1,683,222 | 1,904,775 | |
| Q3 2021 | 937,357 | 1,033,847 | 1,971,204 | 14,175 | 1,600,768 | 1,614,943 | 356,261 | |
| Q4 2021 | 464,215 | 494,878 | 959,093 | 232,968 | 995,386 | 1,228,354 | -269,261 | |
| Q1 2022 | 270,633 | 23,020 | 293,653 | 720,834 | 186,360 | 907,194 | -613,541 | |
| Q2 2022 | 50,364 | 117,738 | 168,102 | 1,353,546 | 321,138 | 1,674,684 | -1,506,582 | |
| Q3 2022 | 114,973 | 15,252 | 130,225 | 217,126 | 1,231 | 218,357 | -88,132 | |
| Q4 2022 | 32,455 | 929,548 | 962,003 | 64,943 | 0 | 64,943 | 897,060 | |
| Q1 2023 | 347,953 | 90,890 | 438,843 | 135,243 | 0 | 135,243 | 303,600 | |